(Q44094170)

29 November 2017

title

Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors (English)

1 reference

29 November 2017

Ryoji Kayasuga

1

1 reference

29 November 2017

Yukio Sugimoto

series ordinal

2

1 reference

29 November 2017

Takeshi Watanabe

series ordinal

3

1 reference

29 November 2017

Chiaki Kamei

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

European Journal of Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

449

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

287-291

1 reference

Histamine--a major role in allergy?

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Pathogenesis of allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Clinical comparison of histamine H1-receptor antagonist drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Pharmacologic heterogeneity of human lung and colon cells: effect of terfenadine and cetirizine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Allergic rhinitis: not purely a histamine-related disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Therapeutic advances in the management of allergic rhinitis and urticaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Vascular permeability in allergic conjunctivitis in mice lacking histamine H1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Active anaphylaxis in IgE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

A new model of allergic rhinitis in rats by topical sensitization and evaluation of H(1)-receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

The role of histamine in allergic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902005-8

10.1016/S0014-2999(02)02005-8

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference